Top View
- Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
- Hereditary Cancer Syndrome Multigene Panels
- PALB2 Genetic Testing for Breast Cancer Risk
- PALB2 Mutations and Breast-Cancer Risk Michele K
- Chapter 1: Diagnosis and Evaluation
- PALB2 Genetic Testing for Breast Cancer Risk
- Integrative Genomic Analysis Implicates ERCC6 and Its Interaction with ERCC8 in Susceptibility to Breast Cancer
- Hereditary Cancer Panel Descriptions
- Novel Strand Exchange Activity of the Human PALB2 DNA Binding 2 Domain and Its Critical Role for DNA Repair in Cells
- PALB2 Is an Integral Component of the BRCA Complex Required for Homologous Recombination Repair
- Pathogenic and Likely Pathogenic Variants in PALB2, CHEK2, and Other Known Breast Cancer Susceptibility Genes Among 1054 BRCA-Negative Hispanics with Breast Cancer
- The Role of PALB2 in BRCA1/2-Mediated DNA Repair and Tumor Suppression DISSERTATION Presented in Partial Fulfillment of the Requ
- Incorporating Truncating Variants in PALB2, CHEK2, and ATM Into the BOADICEA Breast Cancer Risk Model
- USP22 Interacts with PALB2 and Promotes Chemotherapy Resistance Via Homologous Recombination of DNA Double-Strand Breaks Isaac K
- Molecular Characterization of Ductal Carcinoma in Situ: Pilot Studies Neil Bipinchandra Desai Yale University
- Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy?
- Fanconi Anemia (FA) Binding Protein FAAP20 Stabilizes FA Complementation Group a (FANCA) and Participates in Interstrand Cross-Link Repair
- Identification of a Novel Truncating PALB2 Mutation and Analysis of Its
- Breast Cancer High Risk Entended Panel Plus Test Methodology
- Canonical and Noncanonical Roles of Fanconi Anemia Proteins: Implications in Cancer Predisposition
- Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy
- ATM Serine/Threonine Kinase and Its Role in Pancreatic Risk
- Contribution of Known and Novel DNA Repair Genes to Pancreatic Cancer Susceptibility
- Fanconi Anemia Gene Sequencing Panel
- Hereditary Nonmelanoma Skin Cancer Vasiliki Nikolaou, MD,* Alexander J
- PALB2 Genetic Testing for Breast Cancer Risk
- Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 As a Prime Therapeutic Target
- Germline Mutations in DNA Repair Genes Predispose Asbestos-Exposed Patients to Malignant Pleural Mesothelioma
- SWITCH-LIKE PHOSPHORYLATION of WRN INTEGRATES END-RESECTION with REPAIR of Dsbs at REPLICATION FORKS
- Implementation of Massive Sequencing In
- PALB2 Is an Integral Component of the BRCA Complex Required for Homologous Recombination Repair
- PALB 2 Genetic Testing
- DNA Repair in Drosophila: Mutagens, Models, and Missing Genes
- Germline PALB2 Mutation in High-Risk Chinese Breast And/Or Ovarian Cancer Patients
- Common Variants in Mendelian Kidney Disease Genes and Their Association with Renal Function
- Pathogenic Mutations Identified by a Multimodality Approach in 117
- ATM Protein Kinase: Old and New Implications in Neuronal Pathways and Brain Circuitry
- Evaluation of Gene-Specific Cancer Associations and Sensitivity of Genetic Testing Criteria in a Cohort of 165,000 High-Risk Patients
- Prevalence and Clinical Implications of Germline Predisposition Gene
- About Mutations in the PALB2 Gene | Memorial Sloan Kettering Cancer Center
- Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention
- PALB2 Mutations in BRCA1/2-Mutation Negative Breast
- Genetic Testing for Hereditary Cancer – Commercial Medical Policy
- The Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid One Ashburton Place Boston, Massachusetts 02108
- Fanconi Anemia: Guidelines for Diagnosis and Management, Fourth
- Functional Characterization of 84 PALB2 Variants of Uncertain Significance
- PALB2/FANCN: Recombining Cancer and Fanconi Anemia
- The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer
- Tumor Syndromes Predisposing to Osteosarcoma
- BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer: a PACGENE Study
- Tumor Suppressor and DNA Damage Response Panel 1
- Frequency of Pathogenic Germline Variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in Ductal Carcinoma in Situ Diagnosed in Women
- Genomic Instability — an Evolving Hallmark of Cancer
- ATM Mutations in Cancer: Therapeutic Implications Michael Choi, Thomas Kipps, and Razelle Kurzrock
- Differential Expression of DNA Repair Genes in Prognostically-Favorable
- The WD40 Repeat Protein Mutations
- PALB2 Gene Mutation Analysis Assay Summary
- Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers
- DNA Damage Repair As a Target in Pancreatic Cancer: State-Of- The-Art and Future Perspectives Gut: First Published As 10.1136/Gutjnl-2019-319984 on 27 August 2020
- A Genetic Map of the Response to DNA Damage in Human Cells
- PALB2, CHEK2 and ATM Rare Variants and Cancer Risk: Data from COGS
- A Novel Function for FANCJ Helicase in Microsatellite Stabilization During Replication Stress
- Hereditary Breast and Ovarian Cancer Due to Mutations in BRCA1 and BRCA2 Nancie Petrucelli, MS, CGC1, Mary B
- PALB2, CHEK2 and ATM Rare Variants and Cancer Risk: Data from COGS